Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening

被引:3
|
作者
Liebermann, Erica [1 ,2 ]
Fontenot, Holly B. [3 ]
Lim, Eunjung [4 ]
Matsunaga, Masako [4 ]
Zimet, Gregory [5 ]
Allen, Jennifer D. [6 ]
机构
[1] Univ Rhode Isl, Coll Nursing, RINEC, 350 Eddy St, Providence, RI 02903 USA
[2] Univ Rhode Isl, Coll Nursing, Providence, RI USA
[3] Univ Hawaii Manoa, Nancy Atmospera Walch Sch Nursing, Honolulu, HI USA
[4] Univ Hawaii Manoa, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI USA
[5] Indiana Univ, Sch Med, Indianapolis, IN USA
[6] Tufts Univ, Sch Arts & Sci, Dept Community Hlth, Medford, MA USA
关键词
HEALTH-CARE PROVIDERS; WOMEN; ACCEPTABILITY; PARTICIPATION; PERSPECTIVES;
D O I
10.1016/j.jogn.2023.05.114
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: To examine associations among women's preferred locations for human papillomavirus (HPV) self-sampling in relation to their demographic, social, and health characteristics and their perceived benefits and concerns regarding this procedure.Design: Cross-sectional, descriptive survey.Setting: Online distribution between March 2022 and April 2022.Participants: People who were assigned female sex at birth and were eligible for cervical cancer screening (N = 367: cis-gender women, n = 364; another gender identity, n = 3).Methods: We used quota sampling to obtain a racially and ethnically diverse sample. We conducted bivariate analyses to examine differences in participants' preferred locations for HPV self-sampling by sociodemographic and health characteristics. We used a multinomial logistic regression model to examine the associations between preferred HPV self-sampling location, characteristics of participants, and perceived benefits and concerns regarding this procedure.Results: In our sample, 43% (n = 158) of participants preferred HPV self-sampling at the office of a health care provider, 50% (n = 182) preferred HPV self-sampling anywhere (office or home), and 7% (n = 27) did not feel comfortable with HPV self-sampling anywhere. Participants 39 to 45 years of age were more likely to prefer HPV self sampling anywhere (office or home) than participants 27 to 32 years of age, OR = 2.47, 95% confidence interval (CI) [1.21, 5.06]. Participants who preferred HPV self-sampling anywhere perceived greater benefit related to limited geographic access to a clinic compared to those who preferred office only, OR = 1.82, 95% CI [1.08, 3.07]. Participants who preferred HPV self-sampling anywhere had less concern related to performing the procedure accurately than those who preferred office only, OR = 0.44, 95% CI [0.31, 0.62].Conclusion: HPV self-sampling is an alternative strategy to increase cervical cancer screening. As providers consider implementation of HPV self-sampling, our findings suggest that office and home-based collection strategies should be considered to increase access to cervical cancer screening.
引用
收藏
页码:364 / 373
页数:10
相关论文
共 50 条
  • [31] Investigating under-reported human papillomavirus genotypes in Grenadian women through self-sampling for cervical cancer screening
    Mcgill, Frances
    Fields, Paul J.
    Bahadoor-Yetman, Avi
    Manglardi, Erin Salter
    Bailey, Ronelle
    Padala, Kritika
    Lendore, Jessica
    John-Ballantyne, Tiffany
    Lake, Sasha
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2024, 48
  • [32] Human papillomavirus self-sampling with mRNA testing benefits routine screening
    Auvinen, Eeva
    Nieminen, Pekka
    Pellinen, Jukka
    Dillner, Joakim
    Tarkkanen, Jussi
    Virtanen, Anni
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (11) : 1989 - 1996
  • [33] Vaginal self-sampling for HPV in the context of cervical cancer screening
    Springe, L.
    Kivite-Urtane, A.
    Poplavska, E.
    Zodzika, J.
    Berza, N.
    Bukova-Zideluna, A.
    Curkste, A.
    Parna, K.
    Uuskula, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [34] Worldwide use of HPV self-sampling for cervical cancer screening
    Serrano, B.
    Ibanez, R.
    Robles, C.
    Peremiquel-Trillas, P.
    de Sanjose, S.
    Bruni, L.
    PREVENTIVE MEDICINE, 2022, 154
  • [35] Eliminating cervical cancer: tackling inequity through human papillomavirus (HPV) test self-sampling
    Costa, Telma
    Bateson, Deborah
    Broutet, Nathalie
    Saville, Marion
    Canfell, Karen
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2024,
  • [36] Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda
    Ogilvie, Gina S.
    Mitchell, Sheona
    Sekikubo, Musa
    Biryabarema, Christine
    Byamugisha, Josaphat
    Jeronimo, Jose
    Miller, Dianne
    Steinberg, Malcolm
    Money, Deborah M.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2013, 122 (02) : 118 - 123
  • [37] Human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review protocol
    Dzobo, Mathias
    Dzinamarira, Tafadzwa
    Kgarosi, Kabelo
    Mashamba-Thompson, Tivani Phosa
    BMJ OPEN, 2022, 12 (05):
  • [38] Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme
    Enerly, Espen
    Bonde, Jesper
    Schee, Kristina
    Pedersen, Helle
    Lonnberg, Stefan
    Nygard, Mari
    PLOS ONE, 2016, 11 (04):
  • [39] Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer
    Lozar, Taja
    Nagvekar, Rahul
    Rohrer, Charles
    Mandishora, Racheal Shamiso Dube
    Ivanus, Urska
    Fitzpatrick, Megan Burke
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2021, 13 : 841 - 859
  • [40] High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
    Lam, J. U. H.
    Elfstrom, K. M.
    Ejegod, D. M.
    Pedersen, H.
    Rygaard, C.
    Rebolj, M.
    Lynge, E.
    Juul, K. E.
    Kjaer, S. K.
    Dillner, J.
    Bonde, J.
    BRITISH JOURNAL OF CANCER, 2018, 118 (01) : 138 - 144